NICE, under its budget constraints, might have rejected it if it could not secure an extremely low UK price
Exenatide, on the other hand, should be avoided in patients with severe renal impairment (CrCl less than 30 mL/min)
This is especially true of people who need berberine the most individuals with diabetes or pre-diabetes typically have poor gut health and reduced microbiome diversity
[24] Finally, a 2020 Cochrane systematic review found insufficient evidence to suggest that metformin monotherapy reduced all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, or end-stage renal disease when compared to DPP-4 inhibitors for the treatment of type 2 diabetes
an antioxidant cream could also minimize free radical production